(BBWI) Bath & Body Works - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0708301041

Candles, Lotions, Soaps, Sanitizers, Mists

Stock: Other Specialty Retail
Age 40.6y

MCap 4,738m
Avg Vol 5.45M (121M USD)

Beta 1.627
Volatility 45.53%

EPS (Earnings per Share)

EPS CAGR: -39.47%
EPS Trend: -29.7%

Last SUE: -0.60
Qual. Beats: 0

Revenue

Rev. CAGR: -15.73%
Rev. Trend: -20.3%

Last SUE: -1.32
Qual. Beats: 0

Dividends

Dividend Yield	3.26%
Yield on Cost 5y	3.14%
Yield CAGR 5y	-54.94%
Payout Consistency	82.0%
Payout Ratio	24.8%

Risk via 5d forecast
Volatility	45.5%
Value at Risk 5%th	68.2%
Relative Tail Risk	-8.93%

Reward TTM
Sharpe Ratio	-0.50
Alpha	-61.74
CAGR/Max DD	-0.26

Character TTM
Hurst Exponent	0.412
Beta	1.627
Beta Downside	1.813

Drawdowns 3y
Max DD	69.98%
Mean DD	29.44%
Median DD	28.93%

Description: BBWI Bath & Body Works January 09, 2026

Bath & Body Works, Inc. is a specialty retailer focused on home fragrance, personal care, soaps, and sanitizers, offering products such as 3-wick candles, diffusers, fine-fragrance mists, liquid hand soaps, body lotions, and creams.

The company markets its merchandise under the Bath & Body Works, White Barn, and other brand names through a network of over 1,800 retail stores and a growing e-commerce platform in the United States and Canada, while international exposure is provided via franchise, licensing, and wholesale partnerships.

Originally founded in 1963 and formerly known as L Brands, Inc., the firm rebranded to Bath & Body Works, Inc. in August 2021; its headquarters remain in Columbus, Ohio.

BBWI (NYSE) trades as a common stock in the “Other Specialty Retail” sub-industry. In FY 2023 the company generated roughly $3.5 billion in revenue, with comparable-store sales up 5.2% and e-commerce contributing about 30% of total sales-a trend driven by higher consumer spending on discretionary home-and-personal-care items and a resilient fragrance market that is expanding at ~5% CAGR. Operating margins hovered near 12%, reflecting efficient cost control amid modest inflationary pressure on raw materials. For a deeper quantitative dive, see the BBWI analysis on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (699.0m TTM) > 0 and > 6% of Revenue (6% = 441.2m TTM)

FCFTA 0.19 (>2.0%) and ΔFCFTA 6.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 4.46% (prev 1.95%; Δ 2.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.24 (>3.0%) and CFO 1.18b > Net Income 699.0m (YES >=105%, WARN >=100%)

Net Debt (4.74b) to EBITDA (1.50b) ratio: 3.16 <= 3.0 (WARN <= 3.5)

Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (211.6m) change vs 12m ago -3.37% (target <= -2.0% for YES)

Gross Margin 44.13% (prev 43.97%; Δ 0.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 147.5% (prev 149.1%; Δ -1.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.38 (EBITDA TTM 1.50b / Interest Expense TTM 283.0m) >= 6 (WARN >= 3)

Altman Z'' 0.70

(A) 0.07 = (Total Current Assets 1.88b - Total Current Liabilities 1.55b) / Total Assets 4.99b

(B) -0.35 = Retained Earnings (Balance) -1.75b / Total Assets 4.99b

(D) -0.24 = Book Value of Equity -1.57b / Total Liabilities 6.58b

Total Rating: 0.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.72

1. Piotroski 6.0pt

2. FCF Yield 9.98%

3. FCF Margin 12.86%

4. Debt/Equity -3.13

5. Debt/Ebitda 3.16

6. ROIC - WACC (= 32.40)%

7. RoE -46.79%

8. Rev. Trend -20.31%

9. EPS Trend -29.68%

What is the price of BBWI shares?

As of January 18, 2026, the stock is trading at USD 23.27 with a total of 3,546,745 shares traded.
Over the past week, the price has changed by -0.09%, over one month by +18.48%, over three months by -9.39% and over the past year by -34.49%.

Is BBWI a buy, sell or hold?

Bath & Body Works has received a consensus analysts rating of 3.85. Therefore, it is recommended to buy BBWI.

Strong Buy: 7
Buy: 4
Hold: 8
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the BBWI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	23.9	2.8%
Analysts Target Price	23.9	2.8%
ValueRay Target Price	20.4	-12.4%

BBWI Fundamental Data Overview January 14, 2026

P/E Trailing = 7.1146
P/E Forward = 6.3654
P/S = 0.6443
P/EG = 0.9459
Revenue TTM = 7.35b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 3.89b USD (from longTermDebt, last quarter)
Short Term Debt = 193.0m USD (from shortTermDebt, last quarter)
Debt = 4.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.74b USD (from netDebt column, last quarter)
Enterprise Value = 9.48b USD (4.74b + Debt 4.98b - CCE 236.0m)
Interest Coverage Ratio = 4.38 (Ebit TTM 1.24b / Interest Expense TTM 283.0m)
EV/FCF = 10.02x (Enterprise Value 9.48b / FCF TTM 946.0m)
FCF Yield = 9.98% (FCF TTM 946.0m / Enterprise Value 9.48b)
FCF Margin = 12.86% (FCF TTM 946.0m / Revenue TTM 7.35b)
Net Margin = 9.51% (Net Income TTM 699.0m / Revenue TTM 7.35b)
Gross Margin = 44.13% ((Revenue TTM 7.35b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 41.32%)
Tobins Q-Ratio = 1.90 (Enterprise Value 9.48b / Total Assets 4.99b)
Interest Expense / Debt = 1.37% (Interest Expense 68.0m / Debt 4.98b)
Taxrate = 25.24% (26.0m / 103.0m)
NOPAT = 926.2m (EBIT 1.24b * (1 - 25.24%))
Current Ratio = 1.21 (Total Current Assets 1.88b / Total Current Liabilities 1.55b)
Debt / Equity = -3.13 (negative equity) (Debt 4.98b / totalStockholderEquity, last quarter -1.59b)
Debt / EBITDA = 3.16 (Net Debt 4.74b / EBITDA 1.50b)
Debt / FCF = 5.01 (Net Debt 4.74b / FCF TTM 946.0m)
Total Stockholder Equity = -1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.02% (Net Income 699.0m / Total Assets 4.99b)
RoE = -46.79% (negative equity) (Net Income TTM 699.0m / Total Stockholder Equity -1.49b)
RoCE = 51.71% (EBIT 1.24b / Capital Employed (Equity -1.49b + L.T.Debt 3.89b))
RoIC = 38.71% (NOPAT 926.2m / Invested Capital 2.39b)
WACC = 6.31% (E(4.74b)/V(9.72b) * Re(11.87%) + D(4.98b)/V(9.72b) * Rd(1.37%) * (1-Tc(0.25)))
Discount Rate = 11.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF Debug] Terminal Value 84.06% ; FCFF base≈824.8m ; Y1≈783.2m ; Y5≈747.9m
Fair Price DCF = 73.39 (EV 19.77b - Net Debt 4.74b = Equity 15.02b / Shares 204.7m; r=6.31% [WACC]; 5y FCF grow -6.55% → 2.90% )
EPS Correlation: -29.68 | EPS CAGR: -39.47% | SUE: -0.60 | # QB: 0
Revenue Correlation: -20.31 | Revenue CAGR: -15.73% | SUE: -1.32 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.29 | Chg30d=-0.043 | Revisions Net=-1 | Analysts=12
EPS next Year (2027-01-31): EPS=2.59 | Chg30d=-0.161 | Revisions Net=-1 | Growth EPS=-11.5% | Growth Revenue=-2.2%

Additional Sources for BBWI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle